Insufficient scRNA-seq data for expression of PHOX2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 52% | 348.22 | 133 / 258 | 65% | 276.91 | 150 / 230 |
intestine | 94% | 102.34 | 907 / 966 | 2% | 0.05 | 9 / 527 |
ovary | 1% | 0.14 | 2 / 180 | 78% | 29.72 | 335 / 430 |
esophagus | 49% | 42.41 | 713 / 1445 | 4% | 0.29 | 8 / 183 |
stomach | 42% | 49.19 | 149 / 359 | 6% | 0.14 | 17 / 286 |
pancreas | 9% | 1.51 | 28 / 328 | 4% | 0.52 | 8 / 178 |
bladder | 10% | 1.29 | 2 / 21 | 2% | 0.07 | 8 / 504 |
prostate | 8% | 5.06 | 20 / 245 | 1% | 0.03 | 6 / 502 |
breast | 5% | 0.77 | 23 / 459 | 1% | 0.02 | 8 / 1118 |
spleen | 5% | 0.66 | 12 / 241 | 0% | 0 | 0 / 0 |
brain | 3% | 0.97 | 89 / 2642 | 2% | 0.03 | 11 / 705 |
lung | 1% | 0.13 | 5 / 578 | 4% | 0.14 | 44 / 1155 |
uterus | 1% | 0.06 | 1 / 170 | 4% | 0.11 | 17 / 459 |
heart | 3% | 0.56 | 24 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
thymus | 1% | 0.15 | 7 / 653 | 0% | 0.01 | 3 / 605 |
skin | 0% | 0.06 | 9 / 1809 | 1% | 0.03 | 5 / 472 |
liver | 0% | 0.06 | 1 / 226 | 1% | 0.14 | 3 / 406 |
blood vessel | 1% | 0.18 | 15 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.12 | 7 / 929 | 0% | 0 | 0 / 0 |
adipose | 1% | 0.26 | 9 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.04 | 3 / 803 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.00 | 2 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048485 | Biological process | sympathetic nervous system development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0021523 | Biological process | somatic motor neuron differentiation |
GO_0003357 | Biological process | noradrenergic neuron differentiation |
GO_0043576 | Biological process | regulation of respiratory gaseous exchange |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_0021703 | Biological process | locus ceruleus development |
GO_0021623 | Biological process | oculomotor nerve formation |
GO_0021642 | Biological process | trochlear nerve formation |
GO_0030901 | Biological process | midbrain development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PHOX2A |
Protein name | Paired like homeobox 2A Phox2a protein Paired mesoderm homeobox protein 2A (ARIX1 homeodomain protein) (Aristaless homeobox protein homolog) (Paired-like homeobox 2A) |
Synonyms | ARIX PMX2A |
Description | FUNCTION: May be involved in regulating the specificity of expression of the catecholamine biosynthetic genes. Acts as a transcription activator/factor. Could maintain the noradrenergic phenotype. |
Accessions | ENST00000546310.1 H0YGU5 ENST00000298231.5 Q96KQ2 O14813 |